Financial Performance - GAAP net loss for Q3 2025 was $11.1 million, or $1.86 per share, compared to a net loss of $17.1 million, or $2.90 per share in Q3 2024[7] - Non-GAAP adjusted net loss in Q3 2025 was $11.3 million, or $1.91 per share, compared to $17.0 million, or $2.87 per share in Q3 2024[7] Operating Expenses - Total operating expenses decreased by 35% to $11.5 million in Q3 2025 from $17.8 million in Q3 2024[7] - Research and development expenses were $8.0 million in Q3 2025, down 26% from $10.8 million in Q3 2024[7] - Sales and marketing expenses were reduced by 71% to $0.4 million in Q3 2025 from $1.2 million in Q3 2024[7] - General and administrative expenses decreased by 45% to $3.2 million in Q3 2025 from $5.7 million in Q3 2024[7] Cash and Investments - The company had $13.4 million in cash and investments as of September 30, 2025, with a cash burn rate of $10.5 million for Q3 2025[7] - Full year 2025 cash burn is expected to be approximately $50 million[5] - Cash and cash equivalents decreased from $9,737 million in December 2024 to $3,164 million in September 2025, a decline of about 67.5%[21] - Short-term investments fell from $39,360 million in December 2024 to $10,250 million in September 2025, a decrease of approximately 73.9%[21] - The company raised $5.9 million in gross proceeds from a registered direct offering in October 2025[3] Assets and Liabilities - Total current assets decreased from $51,698 million in December 2024 to $15,075 million in September 2025, a decline of approximately 71.1%[21] - Total liabilities decreased from $21,021 million in December 2024 to $15,259 million in September 2025, a reduction of about 27.5%[21] - Stockholders' equity dropped significantly from $46,698 million in December 2024 to $14,088 million in September 2025, representing a decrease of approximately 69.9%[21] - The accumulated deficit increased from $(195,935) million in December 2024 to $(235,602) million in September 2025, indicating a worsening financial position[21] - Total assets decreased from $67,719 million in December 2024 to $29,347 million in September 2025, a decline of about 56.7%[21] - Total current liabilities decreased from $7,667 million in December 2024 to $3,176 million in September 2025, a reduction of approximately 58.6%[21] - Lease liabilities, net of current portion, decreased from $12,567 million in December 2024 to $11,530 million in September 2025, a decline of about 8.3%[21] Strategic Focus - The company is focused on reducing its burn rate while maintaining development timelines[3] - The company maintained restricted cash at $936 million for both periods, indicating stability in this asset category[21]
Vicarious Surgical (RBOT) - 2025 Q3 - Quarterly Results